Hologic, Inc.
$0
▲
0.48%
2026-06-06 08:30:00
www.hologic.com
NMS: HOLX
Explore Hologic, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$16.97 B
Current Price
$0
52W High / Low
$76.07 / $61.28
Stock P/E
31.2
Book Value
$22.68
Dividend Yield
—
ROCE
9.77%
ROE
11.01%
Face Value
—
EPS
$2.41
Exp Qtr EPS
—
Sector
Healthcare
HOLX — Monthly Price History
Adjusted close price · Hover to see price & month
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Intuitive Surgical, Inc. | $422.06 | 50.54 | $150.56 B | — | 15.96% | 16.98% | $603.88 / $396.68 | $50.19 |
| 2. | Becton, Dickinson and Company | $151.16 | 36.88 | $41.96 B | 2.81% | 6.35% | 4.54% | $187.35 / $127.59 | $88.96 |
| 3. | ResMed Inc. | $196.04 | 18.64 | $28.33 B | 1.24% | 23.58% | 24.41% | $293.81 / $180.26 | $40.77 |
| 4. | Alcon Inc. | $66.81 | 40.34 | $26.02 B | 0.01% | 4.77% | 3.71% | $74.34 / $47.8 | $45.21 |
| 5. | West Pharmaceutical Services, Inc. | $314.5 | 41.18 | $22.35 B | 0.33% | 17.6% | 17.87% | $330.88 / $206.8 | $44.11 |
| 6. | Solventum Corporation | $81.01 | 9.8 | $14.03 B | — | 5.66% | 30.71% | $88.2 / $62.38 | $29.1 |
| 7. | The Cooper Companies, Inc. | $67.34 | 32.07 | $12.87 B | 0.02% | 6.05% | 4.83% | $89.83 / $58.89 | $42.06 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 1.05 B | 1.05 B | 1.02 B | 1.01 B | 1.02 B | — |
| Operating Profit | 240.9 M | 252.9 M | 260.9 M | 37.9 M | 233.7 M | — |
| Net Profit | 179.1 M | 187.2 M | 194.9 M | -17.4 M | 201 M | — |
| EPS in Rs | 0.8 | 0.84 | 0.87 | -0.08 | 0.9 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 4.1 B | 4.03 B | 4.03 B | 4.86 B |
| Operating Profit | 785.4 M | 931 M | 761.5 M | 1.63 B |
| Net Profit | 565.7 M | 789.5 M | 456 M | 1.3 B |
| EPS in Rs | 2.53 | 3.54 | 2.04 | 5.83 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 9.01 B | 9.16 B | 9.14 B | 9.07 B |
| Total Liabilities | 3.97 B | 4.03 B | 4.12 B | 4.2 B |
| Equity | 5.05 B | 5.13 B | 5.02 B | 4.88 B |
| Current Assets | 3.67 B | 3.82 B | 4.18 B | 3.86 B |
| Current Liabilities | 977.2 M | 1.04 B | 1.21 B | 937.7 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 1.06 B | 1.29 B | 1.05 B | 2.13 B |
| Investing CF | -482.7 M | -781 M | -152.1 M | -206.3 M |
| Financing CF | -777.2 M | -1.11 B | -483.2 M | -756 M |
| Free CF | 904.7 M | 1.15 B | 901 M | 2 B |
| Capex | -152.4 M | -140.2 M | -150.2 M | -127.2 M |
5Y Margin & Growth History
Last 5 years of annual financial statement data.
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -0% | -17.12% | — | — |
| Earnings Growth % | 73.14% | -64.98% | — | — |
| Profit Margin % | 19.59% | 11.31% | 26.77% | — |
| Operating Margin % | 23.1% | 18.89% | 33.54% | — |
| Gross Margin % | 55.28% | 51.4% | 61.64% | — |
| EBITDA Margin % | 32.16% | 27.56% | 43.46% | — |
Dividend & Split History
Latest dividend payments and stock split events.
Dividend History
No dividend history available.
Stock Splits
No stock split history available.